Details of the Drug
General Information of Drug (ID: DMD47Z9)
| Drug Name |
A-003
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms | LY-433771; Second generation sPLA2 inhibitor (cardiovascular disease), Anthera; Second generation secretory phospholipase A2 inhibitor (cardiovascular disease), Anthera | ||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Structure |
 |
||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
| Drug-Molecule Activity Atlas (DMA)NEW | Click to Jump to the Detailed DMA Information of This Drug | ||||||||||||||||||
| Drug ADMET Endpoint Profile (DAE)NEW | Click to Jump to the Detailed DAE Information of This Drug | ||||||||||||||||||